Do β2 microglobulin levels affect survival of newly diagnosed myeloma patients with translocation t(4;14) or 17p13 deletion treated with conventional chemotherapy?

Documenti analoghi

• The translocation t(4;14) can be present only in minor subclones in multiple myeloma
  di: Hébraud, Benjamin, et al.
  Pubblicazione: (2013)
• The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies
  di: Kalff, A, et al.
  Pubblicazione: (2012)
• MMSET is the key molecular target in t(4;14) myeloma
  di: Mirabella, F, et al.
  Pubblicazione: (2013)
• Treatment of newly diagnosed myeloma
  di: Palumbo, A, et al.
  Pubblicazione: (2008)
• Clinical and Biological Implications of MYC Activation: A common difference between MGUS and newly diagnosed multiple myeloma
  di: Chng, WJ, et al.
  Pubblicazione: (2011)